Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing's syndrome in an adrenal incidentaloma. A case report

Hormone Research

Volumn 50, Issue 4, 1998, Pages 237-242

  Hofle G ^a   Gasser, R W ^a   Lhotta, K ^a   Janetschek, G ^b   Kreczy, A ^a   Finkenstedt, G ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adrenocortical carcinoma; Incidentaloma; Laparoscopic adrenalectomy; o,p' dichlorodiphenyldichloroethane; Preclinical Cushing's syndrome

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTIVIRUS AGENT; CORTICOSTEROID; DOXORUBICIN; KETOCONAZOLE; MITOTANE; SURAMIN;

ABDOMINAL PAIN; ADRENAL CORTEX CARCINOMA; ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; ECHOGRAPHY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADULT; ANDROGENS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CUSHING SYNDROME; DICHLORODIPHENYLDICHLOROETHANE; DOXORUBICIN; FATAL OUTCOME; FEMALE; HUMANS; HYDROCORTISONE; KETOCONAZOLE; SURAMIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031743558     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bertagna Ch, Orth DN: Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951-1978). Am J Med 1981;71:855-875.
2. Charbonel B, Chatal JF, Ozanne P: Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist? J Nucl Med 1981;22:1059-1061.
3. Bogner U, Eggens U, Hensen J, Oelkers W: Incidentally discovered ACTH-dependent adrenal adenoma presenting as 'pre-Cushing's syndrome'. Acta Endocrinol (Copenh) 1986;111:89-92.
4. Seppel T, Schlaghecke R: Subklinischer Hyperkortisolismus bei zufällig entdeckten Nebennierentumoren. Dtsch Med Wochenschr 1996;121:503-508.
5. Osella G, Terzolo M, Borreta G, Magro G, Ali A, Piovesan A, Paccotti P, Angeli A: Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 1994;79:1532-1539.
6. Abecassis M, McLoughlin MJ, Langer B, Kudlow JE: Serendipious adrenal masses: Prevalence, significance, and management. Am J Surg 1985;149:783-788.
7. Hedeland H, Östberg G, Hökfelt B: On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 1968;184:211-214.
8. Ross NS, Aron DC: Hormonal evaluation of the patient with an incidentally discovered adrenal mass (review article). N Engl J Med 1990;323:1401-1405.
9. Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G on behalf of the National Italian Study Group on Adrenal Tumors: Adrenal incidentaloma: An overview of hormonal data from the National Italian Study Group. Horm Res 1997;47:284-289.
10. McLeod MK, Thompson NW, Gross MD, Bondeson AG, Bondeson L: Subclinical Cushing's syndrome in patients with adrenal gland incidentalomas. Am Surg 1990;56:398-403.
11. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W: Preclinical Cushing's syndrome in adrenal 'incidentalomas': Comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992;75:826-832.
12. Hensen J, Buhl M, Bahr V, Oelkers W: Endocrine activity of the 'silent' adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klin Wochenschr 1990;68:608-614.
13. Cutler SJ, Young JL: Third National Cancer Survey: Incidence data. National Cancer Institute Monogr 41, Biometrics Branch, National Cancer Institute. Washington, Government Printing Office, 1975, DHEW publication No. (NIH) 75-787.
14. Copeland PM: The incidentally discovered adrenal mass. Ann Intern Med 1983;98:940-945.
15. Lack EE: Adrenal cortical carcinoma; in Atlas of Tumor Pathology: Tumors of the Adrenal Gland and Extra-Adrenal Paraganglia, ed 3, fasc 19. Washington, Armed Forces Institute of Pathology, 1997, pp 123-150.
16. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat M-H, Louvel A, Chapuis Y, Blondeau P, Bonnin A, Bricaire H: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-1201.
17. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM: Adrenocortical carcinoma: A clinical study and treatment results of 52 patients. Cancer 1995;75:2587-2591.
18. Wooten MD, King DK: Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993;72:3145-3155.
19. Henley DJ, van Heerden JA, Grant CS, Carney JA, Carpenter PC: Adrenal cortical carcinoma: A continuing challenge. Surgery 1983;94:926-931.
20. Norton JA: Adrenal tumors; in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer, Principles and Practice of Oncology, ed 5. Philadelphia, Lippincott-Raven, 1997,pp 1659-1677.
21. Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C: Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992;112:972-980.
22. Pommier RF, Brennan MF: An eleven-year experience with adrenocortical carcinoma. Surgery 1992;112:963-971.
23. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA: Adrenal cortical carcinoma. Cancer 1989;64:765-769.
24. Korobkin M, Francis IR: Adrenal imaging. Semin Ultrasound CT MR 1995;16:317-330.
25. Falke TH, Sandler MP: Classification of silent adrenal masses: Time to get practical (editorial comment) J Nucl Med 1994;35:1152-1154.
26. Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR, Simeone JF: Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179:415-418.
27. Reinig JW: MR imaging differentiation of adrenal masses: Has the time finally come? Radiology 1992;185:339-340.
28. Schröder S, Komminoth P, Padberg B, Heitz PU: Morphologische Typisierung, Dignitätsund Prognosebeurteilung sowie ätiologische Einordnung adrenomedullärer und adrenokortikaler Neoplasien. Pathologe 1995;16:307-314.
29. Vargas MP, Vargas HI, Kleiner DE, Merino MJ: Adrenocortical neoplasms: Role of prognostic markers MIB-1, p53, and RB. Am J Surg Pathol 1997;21:556-562.
30. Weiss LM: Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-169.
31. Slooten van H, Schaberg A, Smeenk D, Moolenaar J: Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985;55:766-773.
32. Hough AJ, Hollifield JW, Page DL, Hartmann WH: Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphological data. Am J Clin Pathol 1979;72:390-399.
33. Schteingart DE, Motazedi A, Noonan RA, Thompson NW: Treatment of adrenal carcinomas. Arch Surg 1982;117:1142-1146.
34. Reymond MA, Schneider C, Hohenberger W, Köckerling F: Pathogenese von Impfmetastasen nach Laparaskopie. Zentralbl Chir 1997;122:387-394.